Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,993,547 papers from all fields of science
Search
Sign In
Create Free Account
adalimumab
Known as:
antibody d2e7
, Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), disulfide with human monoclonal D2E7 light chain, dimer
, Adalimumab [Chemical/Ingredient]
Expand
A recombinant, human IgG1 monoclonal antibody directed against tumor necrosis factor-alpha (TNF-alpha), with immunomodulating activity. Upon…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
20 relations
0.2 ML adalimumab 50 MG/ML Prefilled Syringe
0.2 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]
0.4 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]
0.8 ML adalimumab 50 MG/ML Auto-Injector
Expand
Broader (2)
Anti-Inflammatory Agents
Antirheumatic Agents
Narrower (2)
D2E7 Antibody
Humira
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy.
V. Mishra
,
R. Daniel
,
C. Elmets
,
A. Levin
,
B. Elewski
Journal of Drugs in Dermatology
2013
Corpus ID: 32509859
To the Editor: We report a case of new onset palmoplantar pustulosis and fulminant twenty nail psoriasis in a patient receiving…
Expand
2012
2012
New biologic drugs get under the skin of psoriasis
Sarah C P Williams
Nature Network Boston
2012
Corpus ID: 205379071
2012
2012
Clinical trials: Phase III trial results for tofacitinib bring new oral DMARD therapy a step closer for patients with rheumatoid arthritis
Emma Leah
Nature Reviews Rheumatology
2012
Corpus ID: 30858423
Clinical trials: Phase III trial results for tofacitinib bring new oral DMARD therapy a step closer for patients with rheumatoid…
Expand
2010
2010
Squamous cell carcinoma with osteoclast-like giant cells: 2 cases misdiagnosed as atypical fibroxanthoma.
T. Beer
American journal of dermatopathology
2010
Corpus ID: 196401106
2010
2010
Adalimumab for cutaneous metastatic Crohn's disease.
Dídia B Cury
,
A. Moss
,
G. Elias
,
A. Nakao
Inflammatory Bowel Diseases
2010
Corpus ID: 27979810
To the Editor: Cutaneous manifestations are a common extraintestinal feature of inflammatory bowel disease (IBD). In fact, it has…
Expand
2010
2010
A Case Report of Nephrotic Syndrome Due to Intake of Certolizumab Pegol in a Patient With Crohn's Disease
J. Leong
,
Blanche Fung-Liu
American Journal of Gastroenterology
2010
Corpus ID: 205098229
A Case Report of Nephrotic Syndrome Due to Intake of Certolizumab Pegol in a Patient With Crohn's Disease
2009
2009
Adalimumab treatment for severe recalcitrant chronic plaque psoriasis
Caitriona Ryan
,
Brian Kirby
,
P. Collins
,
S. Rogers
Clincal and Experimental Dermatology
2009
Corpus ID: 38583282
Aim. To assess the efficacy and safety profile of adalimumab in patients with severe, recalcitrant chronic plaque psoriasis, and…
Expand
2009
2009
Efficacy of adalimumab in recalcitrant hidradenitis suppurativa.
E. Sotiriou
,
Z. Apalla
,
E. Vakirlis
,
D. Ioannides
EJD. European journal of dermatology
2009
Corpus ID: 207261510
Auteur(s) : Elena Sotiriou, Zoe Apalla, Eustratios Vakirlis, Demetrios Ioannides First Dermatologic Department, Medical School…
Expand
Review
2007
Review
2007
Adalimumab in the therapy of uveitis in childhood
A. Mansour
British Journal of Ophthalmology
2007
Corpus ID: 19864323
“Adalimumab is more effective” …? Worldwide, around one million patients have been treated with tumour necrosis factor (TNF…
Expand
2007
2007
[Adalimumab therapy for Vogt-Koyanagi-Harada syndrome].
M. DíazLlopis
,
L. Amselem
,
R. Fj
,
S. García-Delpech
,
Hernandez-Hernandez Ml
Archivos de la Sociedad Española de Oftalmología
2007
Corpus ID: 37111158
Dear Sir: The purpose of this letter is to report on the efficiency and advantages of the new anti-TNF therapy with adalimumab in…
Expand